No retraction, correction or concern found when last checked on Nov 3, 2026.
Structural basis of RNA cap modification by SARS-CoV-2
Thiruselvam Viswanathan, Shailee Arya, Siu-Hong Chan and 9 more
Nature Communications · 2020 · CC BY
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19 illness, has caused millions of infections worldwide. In SARS coronaviruses, the non-structural protein 16 (nsp16), in conjunction with nsp10, methylates the 5′-end of virally encoded mRNAs to mimic cellular mRNAs, thus protecting the virus from host innate immune restriction. We report here the high-resolution structure of a ternary complex of SARS-CoV-2 nsp16 and nsp10 in the presence of cognate RNA substrate analogue and methyl donor, S-adenosyl methionine (SAM). The nsp16/nsp10 heterodimer is captured in the act of 2′-O methylation of the ribose sugar of the first nucleotide of SARS-CoV-2 mRNA. We observe large conformational changes associated with substrate binding as the enzyme transitions from a binary to a ternary state. This induced fit model provides mechanistic insights into the 2′-O methylation of the viral mRNA cap. We also discover a distant (25 Å) ligand-binding site unique to SARS-CoV-2, which can alternatively be targeted, in addition to RNA cap and SAM pockets, for antiviral development.
Cited by papers we hold 9
- Ribosome biogenesis in disease: new players and therapeutic targets · 2023No notice
- Structural biology of SARS-CoV-2: open the door for novel therapies · 2022No notice
- SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19 · 2022No notice
- SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8 · 2021No notice
- Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins · 2021Not checked
- COVID-19 Mechanisms in the Human Body—What We Know So Far · 2021Not checked
- SARS-CoV-2: from its discovery to genome structure, transcription, and replication · 2021No notice
- High-resolution structures of the SARS-CoV-2 2′- O -methyltransferase reveal strategies for structure-based inhibitor design · 2020No notice
- The SARS-CoV-2 RNA–protein interactome in infected human cells · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.